Fig. 3From: Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitisTotal subjects included in summary of long-term (≥12 weeks) pediatric trials by therapeutic agent and study duration. a Lighter shading indicates the proportion of patients that received TCS treatment as an active comparator in studies of a TCI. b One of the trials was a 1-yr OL extension of a 1-yr DB study. N = Number of studies. n = Number of subjects in respective treatment groupBack to article page